Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerit Holger Schernthaner

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Journal of Nephrology|June 29, 2013
Diabetic nephropathy: new approaches for improving glycemic control and reducing riskGuntram Schernthaner, Gerit Holger Schernthaner
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic interventionGerit-Holger Schernthaner, Guntram Schernthaner
Diabetes Research and Clinical Practice|November 29, 2019
The right place for metformin todayGuntram Schernthaner, Gerit-Holger Schernthaner
Diabetes & Vascular Disease Research|August 14, 2014
The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal systemGuntram Schernthaner, Carl Erik Mogensen, Gerit-Holger Schernthaner
Angiology|May 21, 2025
FGF-23 and Long-term Outcome in Peripheral Artery DiseaseBernhard Zierfuss, Marija Bojic, Gerit-Holger Schernthaner, et al.
Clinical Therapeutics|May 24, 2016
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes MellitusGuntram Schernthaner, Marie Helene Schernthaner-Reiter, Gerit-Holger Schernthaner
Thrombosis and Haemostasis|October 31, 2021
Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery DiseaseMarija Bojic, Bernhard Bielesz, Daniel Cejka, et al.
Atherosclerosis|March 10, 2023
Secondary calciprotein particle size is associated with patient mortality in peripheral artery diseaseMarija Bojic, Daniel Cejka, Bernhard Bielesz, et al.
Angiology|February 5, 2024
Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery DiseaseGerfried Pesau, Bernhard Zierfuss, Clemens Hoebaus, et al.
Wiener Klinische Wochenschrift|April 8, 2016
[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016]Guntram Schernthaner, Heinz Drexel, Alexander Rosenkranz, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Journal of Nephrology|June 29, 2013
Diabetic nephropathy: new approaches for improving glycemic control and reducing riskGuntram Schernthaner, Gerit Holger Schernthaner
Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum|August 23, 2005
Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic interventionGerit-Holger Schernthaner, Guntram Schernthaner
Diabetes Research and Clinical Practice|November 29, 2019
The right place for metformin todayGuntram Schernthaner, Gerit-Holger Schernthaner
Diabetes & Vascular Disease Research|August 14, 2014
The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal systemGuntram Schernthaner, Carl Erik Mogensen, Gerit-Holger Schernthaner
Angiology|May 21, 2025
FGF-23 and Long-term Outcome in Peripheral Artery DiseaseBernhard Zierfuss, Marija Bojic, Gerit-Holger Schernthaner, et al.
Clinical Therapeutics|May 24, 2016
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes MellitusGuntram Schernthaner, Marie Helene Schernthaner-Reiter, Gerit-Holger Schernthaner
Thrombosis and Haemostasis|October 31, 2021
Calcification Propensity in Serum and Cardiovascular Outcome in Peripheral Artery DiseaseMarija Bojic, Bernhard Bielesz, Daniel Cejka, et al.
Atherosclerosis|March 10, 2023
Secondary calciprotein particle size is associated with patient mortality in peripheral artery diseaseMarija Bojic, Daniel Cejka, Bernhard Bielesz, et al.
Angiology|February 5, 2024
Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery DiseaseGerfried Pesau, Bernhard Zierfuss, Clemens Hoebaus, et al.
Wiener Klinische Wochenschrift|April 8, 2016
[Antihypertensive therapy in diabetes mellitus: Guidelines of the Austrian Diabetes Association 2016]Guntram Schernthaner, Heinz Drexel, Alexander Rosenkranz, et al.
Pageof 8